Epalrestat
Rhif CAS82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Defnyddir epalrestat i atal, lliniaru, a thrin niwroopathi ymylol (fferdod, poen), paresthesia dirgrynol, ac annormaledd cardiaidd sy'n gysylltiedig â diabetes. MANYLEB
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Defnyddir epalrestat i atal, lliniaru, a thrin niwroopathi ymylol (fferdod, poen), paresthesia dirgrynol, ac annormaledd cardiaidd sy'n gysylltiedig â diabetes. MANYLEB
P Enw'r roduct | Epalrestat |
CAS | 82159-09-9 |
MF: | C15H13NO3S2 |
MW: | 319.4 |
Ysgrifennwch eich neges yma a'i hanfon atom ni